volfanhill
Well-Known Member
- Joined
- Jan 5, 2011
- Messages
- 38,378
- Likes
- 71,592
This is evil stuff. Denying a transplant bc the donor won't get vaccinated. Good lord.
Organ transplant patients are at risk from covid, but some donors and recipients are fighting vaccination requirements
That represents about 95% of the people that @mad4vols usually posts about. Some unknown preacher somewhere off the map with about 500 followers... at best.I was thinking the same thing. I have never heard of the guy until Mad4Vax posts
I don't believe that any of the "big 3" therapeutics have been modified with the Delta spike protein sequence.
At best, they are skating where the puck is now and not where it is going. I say at best because I assumed that the original series of vaccines were based on the spike proteins of the most common variant in 2020. By the time they made it to market, there were other variants out there that made them essentially useless.
I'm giving them the benefit of doubt to even suggest this because I'm not sure if they are even modifying anything for this variant or any of the previous ones.
4 people is an incredibly small sample size. Especially if you consider the variants so far are still around 90% asymptomatic/no worse than a cold.Yeah the people who tested positive for it had no symptoms. Maybe it’s finally evolving into weaker and weaker strains like all pandemics eventually do and delta was just an outlier.
What’s wrong with continual boosting? For one thing, a variant may emerge that requires a new vaccine formulation. (Boosting with a Moderna beta variant vaccine yielded higher neutralizing titers against the beta variant than did boosting with Moderna’s original mRNA-1273 vaccine.) We don’t know yet if omicron will require a new formulation, although public health officials are worried it might. In that case, “training” the immune system repeatedly on the original variant — as the current boosters do — may prove to be counterproductive. It could, for instance, diminish the effectiveness of a reformulated booster. In other words, for those not in immediate need of a boost, there may be an advantage to waiting until a booster more closely aligned with circulating variants becomes available.
Here's what I found interesting:
Boosting with the same vax makes little sense. If you must, boost with a new formulation like we do with the flu